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Abstract: Background: Cardiovascular disease (CVD) is a major public health challenge in China.
This study aims to understand the processes of implementing a comprehensive intervention to
reduce CVD events in areas of drug therapy, lifestyle changes, and adherence support in a clustered
randomized controlled trial (cRCT). This trial consisted of 67 clusters spanning over 3 years in
Zhejiang Province, China. Method: A qualitative process evaluation was nested within the cRCT
conducted in 9 township hospitals with 27 healthcare providers, 18 semi-structured interviews,
and 23 observational studies of clinical practices within the intervention arm. Results: Effective and
repeated trainings using an interactive approach were crucial to improve the prescribing behaviour of
family doctors and their patient communication skills. However, the awareness of patients remained
limited, thus compromising their use of CVD preventive drugs and adoption of healthy lifestyles.
Health system factors further constrained providers’ and patients’ responses to the intervention.
Financial barrier was a major concern because of the low coverage of health insurance. Other barriers
included limited doctor–patient trust and suboptimal staff motivation. Conclusion: Our study
suggests the feasibility of implementing a comprehensive CVD risk reduction strategy in China’s rural
primary care facilities. However, health system barriers need to be addressed to ensure the success
and sustainability of the intervention.
Keywords: cardiovascular diseases prevention; primary care; process evaluation; China
1. Introduction
Non-communicable diseases (NCDs), such as cardiovascular disease (CVD), have increasingly
becoming a public health challenge caused by an aging global population [1]. Although primary care
aims to deliver preventive interventions, primary healthcare (PHC) systems in low- and middle-income
countries (LMICs) have limited capacities to provide essential healthcare services to control NCDs [2,3].
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In China, CVD is the leading cause of death. It accounts for 45.01% and 42.61% of total deaths in rural
and urban areas in 2015, respectively [4]. The number of CVD cases is on the rise and predicted to
increase substantially over the next 10 years [4]. In particular, the mortality of the CVD increased
substantially, from 150/100,000 in 1990 to 298.42/100,000 in 2015 in rural areas in China [4]. Despite high
incidences and mortality of CVD in China, there is a lack of operational and clinical guidelines designed
to prevent CVD events for patients with hypertension or diabetes in the PHC facilities including
township hospitals and village clinics.
China has achieved significant progress in strengthening its primary healthcare system. One of
most promising achievements is the implementation of Essential Public Health Service Policy (EPHSP).
In 2009, PHC facilities started to provide essential public health services for hypertensive and diabetic
patients. In many cases, family doctors collaborate with public health doctors, nurses and other PHC
staffs to provide comprehensive public health management for hypertensive and diabetic patients.
These patients receive regular follow-ups from the team based on their diagnoses and disease severities.
In routine practice, family doctors provide basic clinical care for hypertensive and diabetic patients
following the national guidelines. However, these family doctors often provide ad-hoc care, prescribe
medications based on patients’ requests and have limited medical knowledge in the treatment of
hypertension, diabetes, and other CVD-related conditions.
In China, the PHC system faces many challenges. These include increasing numbers of aging
population and high prevalence of NCDs, large turnover rate of village healthcare workers (‘village doctors’),
ineffective financial subsidies creating lack of incentives for cost reduction and health system performance
improvements, inefficient healthcare delivery hindered by insurance policies, low human capacity, poor CVD
preventions, and costly preventive treatments. These factors are particularly true in rural areas with less
developed health services, low patient incomes, and large populations [5–8].
To address the need for improved CVD prevention in China, a comprehensive intervention was
developed to improve CVD preventative care in patients who were hypertensive with a 10-year CVD
risk of >/20% according to the Asian equation, and in patients with high CVD risks from their diabetic
conditions [9]. Major interventions comprised of initial and refresher trainings for providers, a clinical
and prescribing guide, health education, and adherence support. Patients met with their family
doctors on a monthly basis. This could either take place in township hospitals, health stations, village
clinics (branches of township hospitals), or family doctor home visits. Family doctors recommended
low doses of two anti-hypertensive medications (or only one drug if patient is diabetic), a statin and
aspirin (unless contraindicated). In addition, health education regarding smoking cessation, low
salt, oil, and alcohol intake were provided to patients during their monthly follow-up appointments.
Treatment supporters were selected along with patients to encourage adherence to drugs and lifestyle
changes [9]. The care package was designed to be embedded within the essential public health system
in China. Following a pilot study to assess the feasibility of these interventions described above [10],
a cluster randomized controlled trial (cRCT, consisted of 67 clusters) was conducted over a 3-year
timeframe (i.e., December 2013 to March 2017) in Zhejiang Province to evaluate its effectiveness at
reducing the incidences of patients with acute CVD conditions. The interim analysis (published
elsewhere) suggested that the intervention achieved significant improvements in prescribing practices
among family doctors and some lifestyle modifications among patients [11]. Other large CVD
preventative studies have reported the effectiveness of the interventions in LMICs [12,13]. However,
very few have explored the processes to deliver such interventions. This study, conducted alongside
the cRCT, aims to understand the processes of delivering the above interventions and identify factors
affecting its delivery in the health systems.
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2. Materials and Methods
2.1. Study Setting
Zhejiang Province is located in the East Coast of China where CVD is the most common cause
of death [14]. In 2012, incidence and mortality due to acute CVD events, specifically heart diseases
and stroke, were 367.0 and 127.1 per 100,000, respectively. Total case-fatality from CVD events was
34.6% [14]. Since 2009, Zhejiang created a chronic disease surveillance system that covers all counties
in the province [14]. Each health facility is obligated to report CVD events to Zhejiang Provincial
Centre for Disease Control and Prevention. Township hospitals, the major providers of primary care,
are also included in the chronic disease surveillance system [14]. In Zhejiang, the National Rural Health
Insurance Scheme only covered 30% of outpatient costs, thus leaving patients paying the remainder
70% out-of-pocket when we conducted this intervention [11].
2.2. Data Collection
We nested a mixed-method process evaluation within the cRCT (Figure 1), informed by the Grant
et al. framework [15]. In this cRCT, we recruited 13,385 and 14,745 patients in the intervention arm
(34 townships) and control arm (33 townships), respectively. Specifically, 48.1% and 49.6% of the
patients were male; 98.1% and 98.4% were married; 78% and 75% only attended primary school;
the annual household income was 5648 and 6368 USD (1 USD = 6.25 RMB approximately at the time of
study); the annual per capita income was 1920 and 2192 USD; 66% and 62% had hypertension and 34%
and 38% only had diabetes in the intervention and control arm, respectively [11]. Quantitative and
qualitative process data were collected in parallel (quantitative analysis published elsewhere [11]).
The quantitative data was collected to understand the prescription and medication rates, lifestyle
changes, and adherence to appointments, based on clinical follow-up records of 28,130 participating
patients over a 12-month period. Patient surveys were collected at the time of enrolment (baseline),
12 months and 24 months for 950 patients [11]. This paper reported qualitative study results, which were
used to gain insights into real-life implementation processes.
We conducted semi-structured interviews with township hospital directors, family and public
health doctors, and patients in three counties. An interview topic-guide was used, after initial piloting.
In general, the topic guides covered the processes of intervention delivery, such as training of PHC
providers, delivery of evidence-based drug therapies, lifestyle modifications, adherence support,
and health system issues related to the delivery of these interventions. We purposely selected three
township hospitals in each of the three countries, thus nine study sites in total. Providers were selected
based on their profession (1 director; 1 family doctor; 1 public health doctor for each township hospital).
Two patients (high- and low- adherers) based on their drug adherence patterns were selected from
each hospital. In total, we conducted 45 interviews that included 9 directors, 9 family doctors, 9 public
health doctors, and 18 patients who participated in the intervention.
Providers’ and patients’ consent was obtained prior to the interview. Semi-structured interviews
were conducted by three researchers (2 females, 1 male), who were trained on qualitative research
methods between the months of 6 to 12 during the intervention period. Interviews were conducted in
Chinese, audio-recorded, and lasted no more than 30 min.
In addition, 23 structured observations of clinical consultations were conducted during our
quarterly quality control visits to the 13 township hospitals in the intervention group between the
3-month and 12-month periods. An observational checklist was used to assess the utility of desk guide,
prescribing behavior, lifestyle change recommendations, health education and adherence to follow-up
appointments. Researchers also took field notes during these visits.
This study was approved by the University of Leeds Research Ethics Committee on 8 October 2012
(reference HSLTLM/12/010) and the Ethics Committee of Zhejiang Provincial Centre for Disease Control
and Prevention on 18 June 2012.
Int. J. Environ. Res. Public Health 2020, 17, 4156 4 of 13
Figure 1. Flow chart of cRCT at 12-month follow up. Note: Adapted from “Implementation of
a Comprehensive Intervention for Patients at High Risk of Cardiovascular Disease in Rural China:
A Pragmatic Cluster Randomized Controlled Trial.” by Wei et al., 2017, PLoS One 2017, 12 (8), e0183169.
doi.org/10.1371/journal.pone.0183169 [11]. Eligible and exclusion criteria of clusters and patients are
also detailed in that paper [11].
2.3. Data Analysis
The qualitative interview data were analyzed using the Framework Approach [16]. Each audio-recorded
interview was transcribed using Microsoft Word (MS) in Chinese and then imported into NVivo for coding.
Researchers read the initial transcripts twice to gain familiarity with the data (Chinese). A coding framework
was developed prior to the analysis (in English) based on the intervention components and existing literature
and was updated and agreed among the research team per emerging findings. Three researchers participated in
the coding process. Two researchers coded data independently for the initial interviews, and a third researcher
acted as an adjudicator. Consistency in coding was reached before coding the remainder of transcripts.
Data were organized into groups after all transcripts had been coded. Findings from the groups were then
interpreted through discussions and validated by back-checking the original transcripts, before major themes
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were identified. Team collaboration provided ‘analyst triangulation’ to help improve the quality and creditability
of research [17]. Descriptive observation data were integrated with the result of interviews in analysis.
3. Results
3.1. Training of Family Doctors: Interactive Approach Well Received
The significant changes seen in providers’ prescribing behaviors could be attributed to the initial
and refresher training sessions. Generally, training sessions focused on prescribing combined CVD
preventive medications and their side effects. We observed that lower priority was given to lifestyle
modifications during the training sessions. Each 2-h session was presented in PowerPoint slides,
accompanied by interactive elements such as group discussions, role-plays, and question-oriented
segments with handouts. From our previous experience, an interactive training approach could
motivate and engage participants more effectively than the traditional didactic teaching, which is
primarily done with trainers giving the talk and participants receiving the information passively.
For instance, in a scenario-based group discussion in a patient with poorly-controlled diabetes,
we asked the family doctors to discuss appropriate ways of prescribing CVD preventive medicines,
before revealing the best practices for this case. All participating doctors confirmed they have benefited
from attending these training sessions, since the sessions enhanced their understandings of CVD-related
prevention, and also informed them of the most up-to-date prescribing guidelines and practices:
“First of all, the mindset of our medical staffs have changed particularly regarding the combined use of
CVD preventive medicine. Many of us went to training sessions in Shaoxing where we met with
experts in this area. The biggest advantage is that we received updates about standardized medication
in the preventative care of CVD . . . ”
(hospital director, male)
This interactive training approach enabled doctors to understand the new guidelines and improve
their communication skills with patients:
“After the training, I polished my communication skills with patients. I feel closer to them, and there’s
trust formed between us.”
(public health doctor, female)
However, some elderly village clinic doctors who are less educated have demonstrated less
receptivity to interactive training. We found that they were resistant to new guidelines even after the
training and were reluctant to change their practices accordingly.
3.2. Processes of Intervention Delivery
3.2.1. Pharmacological Intervention: Discrepancy between Providers and Patients Responses
The interim analysis showed the prescribing rates of recommended two anti-hypertensive drugs,
a statin and aspirin (unless contraindicated) were significantly higher in the intervention arm than the control
among both hypertensive and patients with diabetes only at the 12-month follow-up [11]. For instance,
around 50%, 91%, and 87% of hypertensive patients were prescribed two anti-hypertensives, aspirin and
statins in the intervention arm as compared with 20%, 1.7%, and 1.0%, respectively, in the control arm [11].
In this study, we observed that of the 23 consultations, 20 family doctors prescribed medications according
to the desk guide, and 18 counseled patients on medication adherence. Doctors were able to discuss the
advantages of taking these preventive measures and the risks of non-adherence to patients. However,
our interviews suggested that it was challenging for family doctors to change their conventional prescribing
patterns, especially those working in the village health stations. While we found significant improvements
in prescribing among family doctors in the intervention arm, patients showed relatively low use of the
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newly-recommended CVD preventative medications [11]. For instance, at 12 months, the drug-taking rates
of two anti-hypertensives were at around 24%, 13%, and 7%, respectively [11]. Our study demonstrated
that patients preferred to continue their current regimen, typically a co-formulation of Chinese traditional
medicine with an old antihypertensive no longer used in Europe. This may be partly due to patients’
outdated medical knowledge, found commonly among the elderly. Also, there was limited awareness of
CVD preventive treatment among patients:
“Doctor prescribed aspirin and a statin, but I don’t take them anymore. My cholesterol is [now]
normal, I feel alright, so I stopped.”
(Patient, male)
3.2.2. Lifestyle Interventions: Communication is Key between Doctors and Patients
Lifestyle education was mainly performed during patient consultations but was also delivered
through proactive phone calls and home visits. In 21 of the 23 observed consultations, family doctors
provided education on healthy lifestyles to patients. Interviews with family doctors indicated that
effective doctor–patient communication was crucial to improving patients’ knowledge in healthy
lifestyles. Most family doctors interviewed have said they would focus on the complications of
hypertension and diabetes, especially to non-adherent patients. The family doctors would also discuss
the social, financial, and medical impact of poorly-chosen lifestyles to patients:
“I warn patients that he/she will have a stroke if continues to drink or smoke, and his/her children will
have to take care of them. That’s a burden to their children . . . As a result, some patients have cut
down their cigarette intake. Some patients used to smoke a pack [20 cigarettes] a day, but now cut
down to probably 7 to 8 cigarettes. It reduced, anyhow.”
(family doctor, male)
Interviews with both doctors and patients suggested the intervention, particularly health education,
helped to improve patients’ awareness of CVD prevention, especially within the scope of healthy
lifestyle. The intervention was associated with positive lifestyle changes among patients in the
intervention arm during Year 1. Smoking rates were significantly reduced (with 4% reduction absolute)
in the intervention arm during the first 12 months compared with the control arm (2.5% increase) [11].
Patients in the intervention arm reported drinking less alcohol (32%) as compared to the control
arm (15%), although not statistically significant [11]. However, many patients interviewed remained
undetermined to lead a meaningful lifestyle change, especially those who are long-term smokers and
drinkers. Although other patients understood the harms of continuing unhealthy lifestyles, they said
it was difficult to stop for social reasons:
“Sometimes I felt ‘mei mian zi’ (‘lose face’ by translation, meaning losing dignity) if I don’t do it
[attend a dinner banquet]. People stigmatizes me if I refused. I have to save my ‘mian zi’ (‘face’), so
I’m obligated to do it even if I didn’t want to.”
(patient, male)
Many family doctors complained only limited consultation time could be allocated to health
education, as it was perceived as time consuming. Our interviews suggested that limited consultation
time compromised the quality of primary care because family doctors faced significant challenges in
work overload and understaffing in order to deliver essential public health services:
“The workload in our clinic is unbearable. We have to measure blood pressure, update medical records
(both paper and electronic) per EPHS standards. We all do it as multiple part-time jobs! Maybe we
didn’t put our hearts into it . . . but we complained about the shortage of hands as well.”
(Hospital director, female)
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3.2.3. Treatment Supporter: Key to Adherence Support
The rate of monthly follow-ups at the intervention sites ranged from 80% to 88%. Most family
doctors reported having followed up on patients averaging 1-3 times a month. We found successful
follow-up adherence with 20/23 (87%) of observed consultations. Most patients were willing to visit
the township hospitals, but the long distance traveled to township hospitals was commonly reported
as a barrier to appointment adherence for patients living in remote areas.
Overall, 93% (11360/12271) of all patients in the intervention arm had a treatment supporter.
Oftentimes, the patient’s spouse or an elderly caregiver was chosen to be the treatment supporter.
Younger people were rarely selected because they migrate to economically-developed cities for better
opportunities. Most patients commented that daily reminders from their treatment supporters were
useful in improving their medical adherence and adapting to a healthier lifestyle:
“If one spouse gets sick, the other usually takes care of him/her. They monitored their medication
usage, and they go for a post-dinner walk on a daily basis. They are co-dependent and hope to grow
healthy together.”
(Hospital director, female)
However, some patients reflected that despite constant reminders from treatment supporters,
they still found it quite difficult to quit smoking. Our interview with providers and patients attributed
this issue to the treatment supporters not having influential positions within the household.
3.3. Health Systems: Relationships, Resources, and Motivation
We found that health system issues affected the delivery of our interventions. These included
doctor–patient relationships, affordable CVD preventative treatments, and motivation among
PHC staffs.
3.3.1. Perceived Poor Doctor–patient Relationship and Trust
Our interviews showed that patients who trusted their family doctors at the township hospitals
were more inclined to accept their recommendations on CVD preventive treatments. However, we also
found patients who mistrusted their family doctors:
“I understand what the doctor is trying to say, [after all] I had been to school for few years. What they
said is one thing, but for me to trust them is another. Most of the time, I don’t trust doctors.”
(Patient, male)
Due to their mistrust on family doctors, many patients preferred to visit a county or tertiary
hospital, even drug stores where most CVD preventative medications are available.
Tension between family doctors and patients was obvious in the study sites. Our intervention
encouraged the prescription of combined CVD preventive medications. However, patients were wary
of the recommended drug therapies from family doctors as they suspected their doctors received
monetary incentives from pharmaceutical companies by promoting new drugs:
“I usually don’t trust doctors; I have seen this a lot on TV. Many doctors go to these TV programs,
and talk about how these drugs will work. There was a TV program that talked about diabetes, and they
are actually selling the drugs. They have to promote drugs eventually . . . ”
(Patient, male)
This suggests that, in addition to commonly-reported reasons such as primary care’s
underdeveloped technical capacity, patients’ perceptions of family doctors are also influenced by the
commercialization of health. Against this backdrop, family doctors were particularly concerned about
potential medical disputes associated with the side effects of certain CVD preventive drugs:
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“The doctor–patient relation is strained in China. We don’t need a lot, one or two cases [of reported
adverse events] is more than enough. Statins have side effects, so does aspirin. If patients don’t trust
doctors in the beginning and the prescribed medications cause side effects, they [patients] will hate the
doctors even more.”
(Hospital director, male)
Indeed, some patients reported side effects from taking CVD preventive drugs with aspirin.
Side effects often discouraged them from taking the medication for long-term health benefits.
As a patient reported:
“After taking aspirin that time, I sensed a really bad heartburn so I stopped. I just had it once or twice.”
(Patient, male)
3.3.2. Poor Affordability of Cardiovascular Disease (CVD) Preventive Medicine
Most township hospitals have a unified approach to drug acquisition through the provincial
health authorities and bidding platforms. However, the township hospitals often failed to purchase
cost-effective essential medicine from the provincial bidding system because the pharmaceutical
companies refused to supply certain drugs due to their low profits. As a result, patients were often
prescribed more expensive medications with similar efficacies, i.e., statins.
As our intervention embedded within routine primary care practices, patients had to pay their
drugs through insurance and/or out-of-pocket bills. Due to the low reimbursement rates from
health insurance, patients often have high out-of-pocket payments. In addition, total reimbursement
was limited per annum (70 USD to 93 USD per person per annum) and could be used up quickly.
On average, patients interviewed spent 16 USD to 160 USD on the CVD preventive drugs per month.
While approximately 50% of interviewed patients complained of the high costs of these medications,
the other half perceived the medication costs as acceptable and believed the CVD preventive medication
was value-for-money. For instance, one patient adhered to the medication despite a high financial
endeavor, as he believed the complications from diabetes would be more significant:
“Taking these drugs cost me a fortune, probably half of my pension. But undoubtedly I still need to
take them. Honestly, I would probably be long gone without taking these medicines.”
(Patient, male)
3.3.3. Poor Motivation of Primary Healthcare Staff
Many family doctors reported their incomes have dropped since the newly implemented
performance-based salary system. In the past, their incomes were associated with the services
provided for patients and bonuses from township hospitals. However, the new performance-based
salary system and the zero-price mark-up policy that no longer allows family doctors to charge patients
15% of the drug costs have ‘demotivated’ family doctors.
4. Discussion
With an increasing aging population in China, PHC system will need to undertake increasing
responsibilities for CVD prevention and treatment. This study is one of the first studies that addressed
the enablers and barriers regarding the delivery of a comprehensive CVD risk reduction strategy of
primary care in rural China (Table 1). Our published quantitative study identified positive responses
and adherence among family doctors in delivering pharmacologic and lifestyle modifying interventions
to high-risk patients [11]. However, the responses and receptiveness of interventions among patients
were mixed, given discrepancies between the rates of prescribing and intake of CVD preventive
medicine [11]. Although the interventions achieved positive lifestyle changes among patients in the
intervention arm, some patients remained undetermined to healthier lifestyles [11].
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Table 1. Enablers and barriers of delivering a comprehensive intervention to reduce the risk of cardiovascular events in primary health care in rural China.
Themes Enablers Barriers
Training of Family Doctors
Interactive training
• Lower priority given to lifestyle modifications;
• Elderly village clinic doctors less receptivity to interactive
training and new guidelines
• motivated and engaged family doctors more effectively
than the traditional didactic teaching enhanced their
understandings of CVD-related prevention;
• informed them the most up-to-date prescribing guidelines
and practices;
• helped them to better understand the new guideline and
improved communication skills with patients
Processes of
Intervention
Delivery
Pharmacological
Intervention
• High provider adherence to prescribed medications;
• Doctors able to discuss the advantages of taking preventive
measures and risks of non-adherence to patients
• Challenging for family doctors to change their conventional
prescribing patterns, especially those working in the village
health stations;
• Low use of CVD preventative medications among patients as
they preferred to continue their current regimen, partly due to
their outdated medical knowledge, commonly among elderly,
and limited awareness of CVD preventive treatment
Lifestyle Intervention
• Good provider adherence to lifestyle education;
• Effective education and doctor–patient communication
crucial to improving patients’ knowledge and awareness in
healthy lifestyles, e.g., discussion of the social, financial,
and medical impact of poorly-chosen lifestyles to patients
• Patients undetermined to lead a meaningful lifestyle change,
especially long-term smokers and drinkers due to social reasons
(e.g., concern of losing face);
• Limited consultation time due to heavy work overload and
understaffing, compromising the quality of education
Follow-up
appointment and
treatment supporters
• Regular follow-up with patients;
• Most patients had a treatment supporter (usually patient’s
spouse or an elderly caregiver);
• Daily reminders from treatment supporters useful in
improving patients’ medical adherence and adapting to
a healthier lifestyle
• Long distance traveled to township hospitals as a barrier to
appointment adherence for patients living in remote areas;
• Effect of treatment supporters could be limited without having
influential positions within the household
Health Systems
Doctor–patient
relations
Patients who trusted their family doctors more inclined to accept
their recommendations on CVD preventive treatments
Mistrust between family doctors and patients not uncommon, due to
perceived pharmaceutical and commercial influence and potential
medical disputes associated with the side effects of certain CVD
preventive drugs
Affordability of CVD
preventive medication Not identified
• Patients were often prescribed more expensive medications with
similar efficacies as township hospitals often failed to purchase
cost-effective essential medicine;
• Low reimbursement from health insurance that drugs costs were
effectively most out-of-pocket
Motivation of primary
healthcare staff Not identified
New performance-based salary system and zero-price mark-up policy
‘demotivated’ family doctors
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By providing effective and repeated trainings using an interactive approach, our study suggests
that this is the key to refine family doctors’ knowledge, attitudes, behaviors, and communication
skills with their patients. However, given the advanced concept of CVD preventive strategy that
advocates for low-dose combined preventive drugs, trainings should be tailored to elderly village
doctors, who have received limited medical training.
Similar to another study [18], this study suggests patients have limited awareness on chronic
disease management. This may contribute to the poor uptake of CVD preventive drugs (low doses of
antihypertensives, statin, and aspirin if not contraindicated), inadequate lifestyle changes, and poor
follow-up visits. Taking large quantities of medicines, often taking 3 to 4 tablets at once, further hinders
medication adherence. China does not have co-formulation of these drugs such as polypill [19].
Patients still preferred their familiar medications including a co-formulation of an old antihypertensive
and traditional Chinese medicine.
Consistent with another study [20], our study suggests social factors are deeply embedded in
the challenges of lifestyles modifications such as smoking and drinking. Future intervention should
strengthen the quality of health education, for instance, to include social elements and relationships
in the delivery of education. This depends on the training of healthcare providers to communicate
effectively with their patients. Similar to a previous study [21], we found that effective communication
acquired from interactive trainings between doctors and patients have increased patients’ awareness
of and adherence to treatments. However, this effect may be limited as our published quantitative
study showed relatively low use of CVD preventive medicine and suboptimal lifestyle modification
amongst the patients with high risk to CVDs [11]. Furthermore, allocating adequate time spent for
physician–patient consultations was challenging in the context of increasing public health workloads
for family doctors, which compromised the quality of education and preventative patient care [22].
Similar to a previous study [23], our study suggests that using treatment supporters improved
patients’ adherence to chronic disease treatments. As population aging becomes more imperative,
it is important to engage family members to support chronic diseases management for the elderly.
While another study in China shows mistrust of patients towards PHC providers in different ownership
models [24], our study suggests that mistrust among patients with high risk to CVDs seek treatment
at the higher-level hospitals instead of PHCs. Again, a previous study showed the importance of
doctor–patient relationship in improving adherence to asthma treatments in China [25]. Yet our study
further identified how doctor–patient relationships could shape the prescribing behavior and facilitate
the use of CVD preventive medicine in the primary care practices. We found that patients who
trusted their family doctors had a high acceptance rate to the recommendations of their preventative
CVD care. Tensions between doctors and patients were apparent in our study observations. This is
likely attributed to patient-perceived physicians’ conflicts of interests from pharmaceutical marketing
(i.e., open endorsement of pharmaceutical products). Family doctors also tended to restrict the
prescription of preventive medications due to concerns of potential medical disputes arising from
possible side effects of certain medications. Indeed, a previous study has suggested that primary
hospitals in China had the highest possibility of experiencing serious workplace violence [26]. Pursuit of
financial incentives at the system-level has led to the eroded patient–physician trust and relationship
in China [27,28].
This study suggests financial barriers remained a critical obstacle hindering patients from
taking preventive medications. The government’s essential medicine-purchasing system fails to
acquire as many generic drugs as possible at a lower price from pharmaceuticals’ influences. In the
PHC post-reform period in China, PHC providers prefer stocking and prescribing more expensive
medications [29]. While a previous study showed by having medical insurance could positively impact
patients’ primary care experiences in China [30], we found that limited reimbursement from rural
health insurance further hindered access to care. Health insurance schemes in China mainly aim to
address catastrophic illness with very limited cost coverage in preventive care [31].
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Although the intervention mainly improves the prescribing behavior of family doctors,
their motivation to improve the quality of primary care may be compromised by the implementation
of a zero-price mark-up policy and an innovative performance-based payment system that lowers
their income. Our trial was one of the first few interventions using comprehensive strategy to reduce
the CVD risk at primary care in LMICs, hence, results of this process evaluation are valuable in the
potential replication of intervention within similar contexts. A systematic qualitative inquiry within
RCTs into aspects of intervention delivery by using multiple methods and triangulated with the
published quantitative results, contributes to the improvement of data interpretation and external
validity [32]. This study was conducted in the initial intervention period rather than in later follow-ups
of this trial. Thus, one must be cautious when applying the results of this study to explain the final
outcome of the trial. However, we believe factors identified in this study influence the execution of the
interventions. This is especially true in health system issues for explaining the final outcome based on
the observation of our continuous follow-ups during the intervention trial period.
5. Conclusions
Our study suggests the feasibilities of implementing a comprehensive CVD risk reduction strategy
in the rural primary care setting. Improving doctor–patient communication and counseling skills
through effective trainings and guidelines are critical to ensure the success of intervention, as this helps
to improve patient awareness, medication use, and lifestyle modifications. However, the success and
sustainability of these interventions will depend on a need to address certain health system issues,
including improving doctor–patient trust and communication, eliminating financial barriers from
health insurance reimbursement policies and drug purchasing system, as well as increasing motivation
among primary care staffs.
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